These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17159717)

  • 61. [Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].
    Goerz G; Hammer G; Wirth G; Hornstein OP; Keller GJ; Altmeyer P; Holzmann H; Meigel W; Mensing H; Braun-Falco O
    Hautarzt; 1986 Jun; 37(6):320-4. PubMed ID: 3522484
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.
    Maricq HR; LeRoy EC; D'Angelo WA; Medsger TA; Rodnan GP; Sharp GC; Wolfe JF
    Arthritis Rheum; 1980 Feb; 23(2):183-9. PubMed ID: 7362667
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Scleroderma.
    Silman AJ
    Baillieres Clin Rheumatol; 1995 Aug; 9(3):471-82. PubMed ID: 7497533
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory.
    Czirják L; Matucci-Cerinic M
    Rheumatology (Oxford); 2011 Feb; 50(2):250-1. PubMed ID: 21115465
    [No Abstract]   [Full Text] [Related]  

  • 65. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
    Roberts H; Curnow PA
    Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud's phenomenon.
    Navon P; Halevi A; Brand A; Branski D; Rubinow A
    Acta Paediatr; 1993 Jan; 82(1):122-3. PubMed ID: 8453211
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fluorescence optical imaging as a novel technique for the visualisation of inflammation in patients with systemic sclerosis with Raynaud's phenomenon: a pilot study.
    Pfeil A; Drummer KF; Oelzner P; Böttcher J; Jung C; Wolf G
    Ann Rheum Dis; 2014 Jun; 73(6):1279-80. PubMed ID: 24532678
    [No Abstract]   [Full Text] [Related]  

  • 68. Diffuse systemic sclerosis and related diseases in Thailand.
    Panicheewa S; Chitrabamrung S; Verasertniyom O; Vanichaphantu M; Kraisit SO; Chiewsilp P; Vatanasuk M
    Clin Rheumatol; 1991 Jun; 10(2):124-9. PubMed ID: 1914410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Criteria for the classification of early systemic sclerosis.
    LeRoy EC; Medsger TA
    J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Scleroderma mimics - Clinical features and management.
    Orteu CH; Ong VH; Denton CP
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101489. PubMed ID: 32147386
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Localized and systemic forms of scleroderma in adults and children .
    Atzeni F; Bardoni A; Cutolo M; Hunzelmann N; Krieg T; Martini G; Montecucco C; Olski TM; Secchi ME; Valentini G; Zulian F; Sarzi-Puttini P
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S36-45. PubMed ID: 16466623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic sclerosis: Current concepts of skin and systemic manifestations.
    Pearson DR; Werth VP; Pappas-Taffer L
    Clin Dermatol; 2018; 36(4):459-474. PubMed ID: 30047430
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New ACR EULAR guidelines for systemic sclerosis classification.
    Johnson SR
    Curr Rheumatol Rep; 2015 May; 17(5):32. PubMed ID: 25874345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Generalized progressive scleroderma with Raynaud's syndrome.
    ARNOLD HL
    Arch Derm Syphilol; 1946 Jan; 53():57. PubMed ID: 21065790
    [No Abstract]   [Full Text] [Related]  

  • 77. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
    Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Classification of progressive systemic scleroderma].
    Holzmann H; Sollberg S; Altmeyer P
    Hautarzt; 1987 May; 38(5):253-7. PubMed ID: 3497136
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New Classification Criteria for Systemic Sclerosis (Scleroderma).
    Pope JE; Johnson SR
    Rheum Dis Clin North Am; 2015 Aug; 41(3):383-98. PubMed ID: 26210125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.